Reagan Jarvis

Company: Anocca

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Validating Immunogenicity of Neoantigens & Establishing a Consensus on Selecting Optimal Neoantigen Targets to Generate an Efficacious Immune Response 12:00 pm

Developing a robust, functional validation platform using effector T-cells to validate neoantigen immunogenicity and avoid systemic toxicity Establishing a consensus on the most appropriate tools and technologies for ranking and selecting the best neoantigens for targeting Characterising neoantigens and selecting an appropriate number for use in therapies to invoke immunogenicity in patientsRead more

day: Day One